Prediction of a sustained viral response in chronic hepatitis C patients who undergo induction therapy with double filtration plasmapheresis plus interferon-β/ribavirin

By                        

Experimental and Therapeutic Medicine, Vol. 9, Iss. 5, 2015-01 ,pp. : 1646-1650

Spandidos Publications

Access to resources Recommend Favorite

Interleukin-28B genotypes determine response to pegylated-interferon plus ribavirin therapy in patients with hepatitis C virus infection

By                    

Molecular Medicine Reports, Vol. 5, Iss. 2, 2012-01 ,pp. : 525-528

Spandidos Publications

Access to resources Recommend Favorite

MHC class I-related chain B gene polymorphism is associated with virological response to pegylated interferon plus ribavirin therapy in patients with chronic hepatitis C infection

By  

Biomedical Reports, Vol. 3, Iss. 2, 2015-01 ,pp. : 247-253

Science Publishers

Access to resources Recommend Favorite

Polymorphism of the inosine triphosphate pyrophosphatase gene predicts ribavirin-induced anemia in chronic hepatitis C patients

By                  

Molecular Medicine Reports, Vol. 5, Iss. 2, 2012-01 ,pp. : 517-520

Spandidos Publications

Access to resources Recommend Favorite

Characteristics and prognosis of hepatocellular carcinoma detected in sustained responders to interferon therapy for chronic hepatitis C

By Toyoda H.   Kumada T.   Hayashi K.   Honda T.   Morita K.   Nishimura D.   Imada K.   Imoto M.   Horiguchi Y.   Nakano H.   Nakano I.   Fukuda Y.   for the Yon-Ken HCV-HCC Follow-up Study Group  

Cancer Detection and Prevention, Vol. 27, Iss. 6, 2003-01 ,pp. : 498-502

Elsevier

Access to resources Recommend Favorite